Agilent Technologies Outlook - Mixed Signals Amid Weak Technicals and Mixed Analyst Views

Market Snapshot

Headline Takeaway: Agilent Technologies (A.N) is under pressure as technical indicators show a weak trend, but recent inflows suggest some positive momentum among institutional investors.

News Highlights

Recent news impacting the broader market includes:

• U.S. COVID-19 Vaccine Policy Shifts: The U.S. Department of Health and Human Services has revised guidelines for vaccine approvals and recommendations, which could influence broader healthcare sector sentiment and indirectly affect Agilent.
• Utah Uranium Mine Revival: Under President Trump, the fast-tracking of a uranium mine in Utah signals potential industry revival, though industry recovery is likely dependent on rising prices — a development that could influence capital allocation in related tech and energy sectors.
• China’s Factory Activity: While China’s factory activity contracted in May, there are early signs of stabilization following a U.S.-China tariff deal. This could help stabilize global supply chains, indirectly supporting Agilent’s operations and demand for its products.

Analyst Views & Fundamentals

The analyst consensus for Agilent Technologies shows a simple average rating of 3.50, with a performance-weighted rating of 2.56. The ratings are mixed, with two "Buy" and two "Neutral" ratings from four active analysts in the last 20 days.

Analysts include representatives from Baird, Barclays, Evercore ISI Group, and Wells Fargo. However, the historical performance of these analysts and institutions varies. For example, Baird and Wells Fargo have a 33.3% historical win rate, while Barclays holds a strong 66.7% win rate.

The current price trend is downward, with a drop of 1.93% recently. This price movement aligns with the weighted analyst expectations, which remain neutral.

Key fundamental factors:

• Revenue-MV: A value of -0.61, indicating a weaker revenue-to-market value.
• Net profit attributable to parent company shareholders / Net profit (%): A value of 100.00%, meaning all net profit is attributable to parent shareholders.
• Basic earnings per share (YoY growth rate %): A value of -16.52%, showing a negative trend in earnings growth.
• Total profit (YoY growth rate %): A value of -19.31%, indicating a significant decline in total profit.
• Non-current liabilities / Total liabilities (%): A value of 66.59%, suggesting a high proportion of long-term liabilities.

Money-Flow Trends

Despite the recent price decline, money-flow patterns show positive inflow trends. The overall inflow ratio is 50.52%, with large and extra-large institutional investors contributing a positive trend. Notably, the fund-flow score is 7.95, which is considered good, indicating strong institutional support.

Key Technical Signals

Internal diagnostic scores (0-10) for key indicators:

• WR Overbought: Score of 2.17 — weak signal for potential overbought conditions.
• WR Oversold: Score of 1.75 — very weak signal, suggesting poor timing for entry.
• RSI Overbought: Score of 3.33 — neutral bias, not strongly bearish.
• MACD Death Cross: Score of 2.64 — bearish confirmation of a downtrend.

Recent chart patterns include a MACD Death Cross and WR Oversold signals on September 12, 2025. These suggest continued downward pressure and caution for new buyers.

Key Insights: The technical trend is weak with 4 bearish vs 0 bullish indicators. Investors are advised to avoid this stock due to the high risk of further declines.

Conclusion

Agilent Technologies is currently facing a challenging technical outlook and mixed analyst views. While institutional flows are positive, the stock's technical indicators suggest caution. The internal diagnostic score of 2.47 reinforces the bearish bias. Investors should consider waiting for a pull-back or a clearer technical reversal before considering new positions.